Name
Session 3: Next Steps
Date & Time
Monday, September 16, 2024, 4:00 PM - 4:50 PM
Speakers
Mr. Hiiti SILLO, Unit Head, Regulation and Safety, WHO
Mr. André Breisinger, Medical Devices Regulation Expert, Swissmedic
Dr. Shang-Ching Lin, Associate Researcher, Taiwan Food and Drug Administration (TFDA)
Mr. Naoki MOROOKA, Senior General Manager of Medical Regulatory Policy, Shimadzu Corporation
Raina Dauria, VP, Global Regulatory Policy, MedTech, Johnson & Johnson
Dr. Ken Cavanaugh Jr, Deputy Director, Office of Cardiovascular Devices, Center for Devices and Radiological Health, US FDA
Olga van Grol-Lawlor, Senior Global Regulatory Intelligence & Advocacy Manager, Boston Scientific
Hiiti SILLO André Breisinger Shang-Ching Lin Naoki MOROOKA Raina Dauria Ken Cavanaugh Olga van Grol-Lawlor
Description

Panel Discussion

  • TBD, China National Medical Products Administration (NMPA)
  • Andre Breisinger, Medical Devices Regulation Expert, Swissmedic
  • TBD, Tanzania Medicines and Medical Devices Authority (TMDA)
  • Shang-Ching Lin, Associate Research, Taiwan Food and Drug Administration, on behalf of Asia-Pacific Economic Cooperation (APEC)
  • Hiiti Sillo, Unit Head, Regulation and Safety, Regulation and Prequalification Department, World Health Organization (WHO)
  • Naoki Morooka, Senior General Manager, Medical Regulatory Policy Department, Shimadzu Corporation
  • Raina Dauria, Vice President, Global Regulatory Policy, Johnson & Johnson MedTech
  • Kenneth Cavanaugh, Center for Devices and Radiological Health, US FDA
  • Olga van Grol-Lawlor, Senior Global Regulatory Intelligence & Advocacy Manager, Boston Scientific

4:00-4:50 PM
Location Name
Grand Pacific Ballroom
Full Address
Seattle Marriott Waterfront
2100 Alaskan Way
Seattle, WA 98121
United States
Session Type
General Session